Table of Content


List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Meningioma - Overview
Meningioma - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Meningioma - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Meningioma - Companies Involved in Therapeutics Development
Advanced Accelerator Applications SA
AptaBio Therapeutics Inc
AstraZeneca Plc
BNOAT Oncology Inc
Boehringer Ingelheim Intertiol GmbH
Bristol-Myers Squibb Co
Clarity Pharmaceuticals Pty Ltd
Eli Lilly and Co
Merck & Co Inc
Merck KGaA
Ono Pharmaceutical Co Ltd
Pharma Mar SA
Progenics Pharmaceuticals Inc
Recordati SpA
Recursion Pharmaceuticals Inc
Meningioma - Drug Profiles
Meningioma - Dormant Projects
Meningioma - Discontinued Products
Meningioma - Product Development Milestones
Appendix



List of Figures


Number of Products under Development for Meningioma, H2 2019
Number of Products under Development by Companies, H2 2019
Number of Products by Top 10 Targets, H2 2019
Number of Products by Stage and Top 10 Targets, H2 2019
Number of Products by Top 10 Mechanism of Actions, H2 2019
Number of Products by Stage and Top 10 Mechanism of Actions, H2 2019
Number of Products by Top 10 Routes of Administration, H2 2019
Number of Products by Stage and Top 10 Routes of Administration, H2 2019
Number of Products by Molecule Types, H2 2019
Number of Products by Stage and Molecule Types, H2 2019


List of Tables


Number of Products under Development for Meningioma, H2 2019
Number of Products under Development by Companies, H2 2019
Number of Products under Development by Universities/Institutes, H2 2019
Products under Development by Companies, H2 2019
Products under Development by Universities/Institutes, H2 2019
Number of Products by Stage and Target, H2 2019
Number of Products by Stage and Mechanism of Action, H2 2019
Number of Products by Stage and Route of Administration, H2 2019
Number of Products by Stage and Molecule Type, H2 2019
Meningioma - Pipeline by Advanced Accelerator Applications SA, H2 2019
Meningioma - Pipeline by AptaBio Therapeutics Inc, H2 2019
Meningioma - Pipeline by AstraZeneca Plc, H2 2019
Meningioma - Pipeline by BNOAT Oncology Inc, H2 2019
Meningioma - Pipeline by Boehringer Ingelheim International GmbH, H2 2019
Meningioma - Pipeline by Bristol-Myers Squibb Co, H2 2019
Meningioma - Pipeline by Clarity Pharmaceuticals Pty Ltd, H2 2019
Meningioma - Pipeline by Eli Lilly and Co, H2 2019
Meningioma - Pipeline by Merck & Co Inc, H2 2019
Meningioma - Pipeline by Merck KGaA, H2 2019
Meningioma - Pipeline by Ono Pharmaceutical Co Ltd, H2 2019
Meningioma - Pipeline by Pharma Mar SA, H2 2019
Meningioma - Pipeline by Progenics Pharmaceuticals Inc, H2 2019
Meningioma - Pipeline by Recordati SpA, H2 2019
Meningioma - Pipeline by Recursion Pharmaceuticals Inc, H2 2019
Meningioma - Dormant Projects, H2 2019
Meningioma - Discontinued Products, H2 2019